Search Results 1641-1650 of 23442 for Lesion

  1. A Study Assessing the Effectiveness and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced Triple Negative Breast Cancer - Mayo Clinic

    ... lesion or mixed lytic-blastic bone lesion with identifiable soft tissue component (that can be evaluated by CT/MRI) must be present Part B1: patients must ...

  2. Radiology - Clinical trials

    The primary purpose of this study is to compare the diagnostic utility of 7T MRI versus 3T MRI in the detection of subtle epileptogenic lesions in the brain.

  3. A Phase 1B Dose-escalation Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma - Mayo Clinic

    Patients with radiated or resected lesions are permitted, provided the lesions are fully treated and inactive, patients are asymptomatic, and no steroids ...

  4. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

    Be willing to provide FNA of a tumor lesion. Newly-obtained is defined as a specimen obtained up to 6 weeks (42 days) prior to initiation of treatment on Day 1.

  5. Hidradenitis suppurativa - Doctors and departments - Mayo Clinic

    Imhof, M.D.. Dermatologist. Rochester, MN. Areas of focus: Skin biopsy, Botox injection, Pulsed-dye laser therapy, Laser hair removal, Skin lesion removal, ...

  6. Study of VS-6766 + Adagrasib in KRAS G12C NSCLC Patients - Mayo Clinic

    Measurable disease according to RECIST 1.1 with at least 1 measurable disease lesion. ... Note: palliative radiation, other than to target lesions, is ...

  7. A Study to Evaluate Yttrium-90 Therapy for Radiation Lobectomy - Mayo Clinic

    AFP > 200 and radiological evidence (arterial hypervascularity) of lesion > 2 cm does not require biopsy;; Two imaging modalities (triphasic CT, MRI ...

  8. Multimodal Biomarkers to Identify a Lewy Body Disease Neurodegeneration Index - Mayo Clinic

    ... lesion. In addition, as necessitated by the risks of Magnetic Resonance Imaging (MRI), patients who have any type of implanted electrical device (such as a ...

  9. A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer (MOUNTAINEER-03) - Mayo Clinic

    ... lesion is required within 35 days prior to start of study treatment. HER2+ disease as determined by a tissue based assay performed at a central laboratory ...

  10. Publications - Candice W. Bolan, M.D. - Mayo Clinic

    ... lesions in prostate MRI. PLoS One. 2022; 17 (5):e0268829 Epub 2022 May 23. View PubMed; Takahashi H, Vikram R, Jimenez RE, Bolan CW, Kawashima A, Karam JA ...